Tom Keith-Roach, president of AstraZeneca UKsaid Wednesday that they are preparing to make more than 2 million doses of their coronavirus vaccine available in the UK shortly, as reported by Reuters.
The company reported that the production of the vaccine is a 3-4 month process and that it can offer great visibility of the supply schedule until the end of the first quarter.
“Process optimization can make over 2 million doses a week possible for the UKbut I can’t commit to that, “Keith-Roach said.
COVID outbreaks are hampering the vaccine development workforce, the AstraZeneca president justified. He added that they have requested that vaccine developers and trial staff have priority to receive an injection.